Science Talks: Tackling Ebola
Science Talks – An Educational Webinar Series from Wiley for Journalists
The Association of Health Care Journalists (AHCJ) is pleased to provide ongoing training and support for new and seasoned health reporters. As part of our partnership with Wiley we offer members access to an educational series of webinars called Science Talks that are brought to you by The Wiley Network.
This webinar, Science Talks with Dr. Peter Halfmann was recorded on July 24, 2018.
In this session, Tackling Ebola, media will learn:
The current situation in regions affected by the Ebola virus and if there is still any danger.
Where we stand with the research on finding a vaccine and if the latest trials on humans proofed successfully.
When the vaccine will be made available for humans affected in regions by the Ebola virus.
What the future will bring in terms of infectious diseases, such as Ebola.
How local journalists can better report on infectious diseases including: what they should look for, what kind of questions to ask, what resources they should use.
The webinar will include time for questions and answers.
HOW TO REGISTER?
Science Talks webinars are complimentary to AHCJ members. Register for Science Talks today!
If you are not able to attend the live one-hour session the webinars will be recorded for later viewing on the AHCJ website.
About Peter Halfmann, Ph.D.
University of Wisconsin, B.S. Bacteriology
University of Wisconsin, Ph.D. Cellular and Molecular Biology
Initially Halfmann wanted to pursue a medical degree after his undergraduate studies, but he became interested in infectious diseases and viruses, particularly Ebola virus, after reading Richard Preston’s “The Hot Zone.” At the beginning of his junior year, he sought out a lab at the University of Wisconsin that focused its research on virus pathogenesis and discovered the lab of Dr. Yoshihiro Kawaoka, a professor at the School of Veterinary Medicine and a world expert on influenza virus.
After being told that influenza viruses were as interesting as Ebola virus, Halfmann started his career in the Kawaoka group. He was a student research assistant for two years, then, after graduating with a bachelor’s degree in bacteriology, he was a technician for one year before starting graduate school in the Cellular and Molecular Biology program with Dr. Kawaoka as his mentor. Unable to conduct research with authentic Ebola virus in Wisconsin, Halfmann developed a novel, biologically-contained Ebola virus as part of his graduate thesis research. The biologically-contained virus resembled authentic Ebola virus, but could be handled safely under non-biosafety level-4 containment. Besides being an important research tool, Halfmann demonstrated that the biologically-contained virus could also be used as a whole-virus vaccine to protect against Ebola virus infection.
In 2008, Halfmann earned his Ph.D. and decided to continue his research with Dr. Kawaoka. He received biosafety level-4 training at the NIAID’s Rocky Mountain Laboratories from Dr. Heinz Feldmann. As part of his high containment research, he continued to evaluate his Ebola vaccine. During the height of the Ebola outbreak in West Africa, Halfmann established a research lab at 34 Military Hospital in Freetown, Sierra Leone to examine the body’s responses to Ebola virus infection. Currently, Halfmann is a Research Associate Professor at the Influenza Research Institute (part of the University of Wisconsin) and manages the Ebola research efforts in the Kawaoka group. With support from the Japanese government, his vaccine is currently being produced at Waisman Biomanufacturing for a human clinical research trial in Japan. Peter still travels to Sierra Leone to follow-up with Ebola survivors and to conduct surveillance studies to identify neglected and novel viruses circulating in Sierra Leone.
About The Wiley Network
Wiley believes the most successful individuals never stop learning. The Wiley Network draws on trusted Wiley authors, partners, and subject matter experts as well as professional leaders to share their knowledge and experiences to support learning and professional growth. Explore contributions from industry thought-leaders—from those with years of experience to those just starting out. Take advantage of white papers, infographics, interviews, opinion pieces, industry updates, videos, and more to help you stay ahead of the changing world. Customize your experience on The Wiley Network site by selecting your favorite subjects and interests.
Wiley, a global research and learning company, helps people and organizations develop the skills and knowledge they need to succeed. Our online scientific, technical, medical, and scholarly journals, combined with our digital learning, assessment and certification solutions help universities, learned societies, businesses, governments and individuals increase the academic and professional impact of their work. For more than 210 years, we have delivered consistent performance to our stakeholders. The company's website can be accessed at www.wiley.com.